tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SNGX Stock Latest News

Soligenix completes enrollment of patients for Phase 3 study evaluating HyBryte
The FlySoligenix completes enrollment of patients for Phase 3 study evaluating HyBryte
15d ago
SNGX
Soligenix Regains Nasdaq Compliance as of November 2025
PremiumCompany Announcements
Soligenix Regains Nasdaq Compliance as of November 2025
16d ago
8K
SNGX
Soligenix, Inc. Reports Q3 2025 Financial Results
PremiumCompany Announcements
Soligenix, Inc. Reports Q3 2025 Financial Results
26d ago
SNGX
Is SNGX a Buy, Before Earnings?
PremiumPre-Earnings
Is SNGX a Buy, Before Earnings?
29d ago
SNGX
Soligenix’s Phase 3 Study on HyBryte™: A Potential Game-Changer for CTCL Treatment
PremiumCompany Announcements
Soligenix’s Phase 3 Study on HyBryte™: A Potential Game-Changer for CTCL Treatment
1M ago
SNGX
Soligenix’s Promising Phase 2 Study on SGX302 for Psoriasis: A Potential Game-Changer
PremiumCompany AnnouncementsSoligenix’s Promising Phase 2 Study on SGX302 for Psoriasis: A Potential Game-Changer
1M ago
SNGX
Soligenix’s HyBryte achieves safety milestone in Phase 3 T-cell lymphoma trial
Premium
The Fly
Soligenix’s HyBryte achieves safety milestone in Phase 3 T-cell lymphoma trial
2M ago
SNGX
Soligenix expands European Medical Advisory Board for CTCL
Premium
The Fly
Soligenix expands European Medical Advisory Board for CTCL
2M ago
SNGX
Soligenix Raises $7.5 Million in Public Offering
PremiumCompany Announcements
Soligenix Raises $7.5 Million in Public Offering
2M ago
8K
SNGX
Soligenix files to sell 2.91M shares of common stock, 2.91M warrants
PremiumThe Fly
Soligenix files to sell 2.91M shares of common stock, 2.91M warrants
3M ago
SNGX
Soligenix’s ThermoVax platform shows efficacy in vaccine stability
PremiumThe Fly
Soligenix’s ThermoVax platform shows efficacy in vaccine stability
3M ago
SNGX
Soligenix Inc. Reports Q2 2025 Earnings Loss
PremiumCompany Announcements
Soligenix Inc. Reports Q2 2025 Earnings Loss
3M ago
SNGX
3 Penny Stocks to Watch Now, 8/19/25
PremiumMarket News3 Penny Stocks to Watch Now, 8/19/25
4M ago
SNGX
VTAK
Soligenix Gains FDA Orphan Drug Designation for Dusquetide
Premium
Company Announcements
Soligenix Gains FDA Orphan Drug Designation for Dusquetide
4M ago
8K
SNGX
Soligenix’s dusquetide granted Orphan Drug Designation in Behcet’s Disease
Premium
The Fly
Soligenix’s dusquetide granted Orphan Drug Designation in Behcet’s Disease
4M ago
SNGX
Soligenix Faces Nasdaq Non-Compliance Notice
PremiumCompany Announcements
Soligenix Faces Nasdaq Non-Compliance Notice
4M ago
8K
SNGX
Soligenix receives FDA orphan designation for dusquetide
PremiumThe Fly
Soligenix receives FDA orphan designation for dusquetide
4M ago
SNGX
Soligenix Completes Promising Study on Dusquetide for Behcet’s Disease
PremiumCompany Announcements
Soligenix Completes Promising Study on Dusquetide for Behcet’s Disease
4M ago
SNGX
Why Is Soligenix Stock (SNGX) Up 50% Today?
PremiumMarket News
Why Is Soligenix Stock (SNGX) Up 50% Today?
4M ago
SNGX
Soligenix Completes Phase 2a Study for SGX945
PremiumCompany AnnouncementsSoligenix Completes Phase 2a Study for SGX945
4M ago
8K
SNGX
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
4M ago
MA
UL
Soligenix’s Phase 3 Study on HyBryte for CTCL: Key Insights for Investors
Premium
Company Announcements
Soligenix’s Phase 3 Study on HyBryte for CTCL: Key Insights for Investors
4M ago
SNGX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >